Scientific Review of FDA's Draft Risk Profile on Spices
This document is a letter from February 2014 from James S Dickson to ASTA containing a scientific review of the FDA's Draft Risk Profile on Spices.
02/28/2014 at 5:15 am
1
Related Resources
Multi-Industry Comments on FDA's Tool for the Prioritization of Food Chemicals for Post-Market Assessment
In August 2025, ASTA signed onto comments written by the Food & Beverage Issue Alliance (FBIA) encouraging FDA to leverage a science-driven, iterative approach for the prioritization of chemicals for post-market assessments. The comments call for FDA to place greater weight on public health risk-related factors, differentiate prioritization and assessment frameworks between intentionally added substances and contaminants, and to enhance transparency and stakeholder engagement opportunities.
Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
